comprehensive -WSS

comprehensive

author：leisure time 2025-09-02 22:22:28 - browse：8113

RHONA WISE/AFP via Getty Images

WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new obesity drugs, and they might get some government help. The agency that regulates Obamacare insurance is considering a technical change that would require insurers to cover obesity drugs in a market of more than 20 million Americans.

Weight loss drugs are a blessing for patients, a boon for drugmakers, and a potentially huge expense for insurers and taxpayers. Insurers have been slow to cover the drugs, called GLP-1 agonists, and without insurance, it costs upward of $16,000 annually for a drug that must be taken indefinitely.

There is a lot of demand for the drugs, but there are barriers to coverage. Medicare by law is prohibited from paying for obesity drugs. State Medicaid programs don’t have to cover them, so most don’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： A new approach to psychiatric drug development

WSS

Here's how to stay safe from wildfire smoke amid reduced air quality

ADA: All diabetes patients should be screened for liver condition

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Longer MASH drug regimen improved liver, Akero study finds

Lack of health data on LGBTQ+ people has serious consequences

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

focus

comprehensive

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Illumina to lay off 10% of research and development team

The cancer drug shortage isn’t new — and neither are the solutions

Medicare drug price negotiation continues, as pharma counteroffers

Jerome Adams on the need for new antivirals for Covid

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Apple is now the first public company to be valued at $3 trillion

For AI in health care standards, federal regulators join with industry group

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

leisure time

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Why Talkspace is targeting Medicare, a tricky market

Supreme Court rules employers must be more accommodating of religious observance

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Ukrainian soldiers say they owe lives to US

Immune cells and nerve overgrowth may explain recurring UTI pain

knowledge

focus

leisure time

Wikipedia